Table 2.
Metabolic parameters, kidney weight and renal function
Ctrl | Ctrl‐FL‐926‐16 | Diab | Diab‐FL‐926‐16 | |
---|---|---|---|---|
Body weight, g | 34.5 ± 3.0 | 33.8 ± 1.7 | 45.5 ± 2.0* | 45.6 ± 7.6* |
Glucose, mmol·L−1 | 9.18 ± 0.43 | 9.11 ± 0.63 | 29.74 ± 2.43* | 28.95 ± 2.38* |
Insulin, pmol·L−1 | 72.6 ± 8.1 | 73.0 ± 10.5 | 254.4 ± 18.8* | 251.3 ± 15.6* |
HOMA‐IR | 4.27 ± 0.51 | 4.23 ± 0.49 | 48.20 ± 1.81* | 46.39 ± 1.91* |
Cholesterol, mmol·L−1 | 1.98 ± 0.24 | 1.98 ± 0.15 | 3.80 ± 0.41* | 3.81 ± 0.40* |
Triglycerides, mmol·L−1 | 0.76 ± 0.10 | 0.77 ± 0.07 | 1.09 ± 0.10* | 1.06 ± 0.10* |
8‐epi‐PGF2α, pg·mL−1 | 71.0 ± 4.7 | 70.4 ± 2.4 | 165.6 ± 8.8* | 77.6 ± 13.3† |
PCOs, pmol·mg·prot−1 | 1.57 ± 0.06 | 1.56 ± 0.13 | 3.12 ± 0.34* | 1.94 ± 0.16† |
AGEs, U·mL−1 | 5.37 ± 0.64 | 4.94 ± 0.83 | 10.57 ± 1.30* | 6.67 ± 1.09† |
Pentosidine, pg·mL−1 | N/A | N/A | N/A | N/A |
P‐FL‐926‐16, μmol·L−1 | N/A | N/A | N/A | N/A |
U‐FL‐926‐16, μmol·L1 | N/A | N/A | N/A | N/A |
Kidney weight, mg | 234.0 ± 19.5 | 232.0 ± 14.8 | 278.0 ± 14.8* | 256.0 ± 11.4 |
Creatinine, μmol·L−1 | 31.5 ± 1.3 | 31.3 ± 1.6 | 62.1 ± 6.4* | 50.7 ± 5.9*, † |
Urinary P/C, mg·g−1 | 2.03 ± 0.32 | 2.08 ± 0.09 | 44.65 ± 7.89* | 28.04 ± 4.84*, † |
Urinary A/C, mg·g−1 | 1.42 ± 0.23 | 1.43 ± 0.22 | 33.48 ± 4.96* | 19.65 ± 2.63*, † |
Values of untreated and FL‐926‐16‐treated db/m and db/db mice at 34 weeks of age (regression protocol; n = 5 per group).
Kidney weight refers to both kidneys. HOMA‐IR, Homeostasis Model of Assessment – Insulin Resistance; N/A, not assessed; Post hoc multiple comparison:
P < 0.05 versus Ctrl;
P < 0.05 versus Diab.